Alzheimers

Dr. Dale Bredesen brings a personalized medicine approach to Alzheimer's treatment and he's seeing success and improvements in brain function.

Most everyone knows of a cancer survivor. But, by and large, when a person receives a diagnosis of Alzheimer's disease, it is often assumed that this is an indication of an almost certain outcome. Alzheimer's disease is not caused by a specific flaw. While energy deficiency, inflammation, infectious agents, beta amyloid, acetylcholine deficiency, trauma, toxins, metabolic issues, and genetics are all worthy of consideration, it is clearly myopic to consider that targeting one of these popular ideas is going to solve the problem. It doesn’t. Our guest today has taken a different approach. Rather than trying to find a unique drug or technique that can help the Alzheimer's population at large, this novel approach focuses on identifying how variations in multiple parameters can be targeted with the overall goal of improving brain functionality that is compromised in the developing Alzheimer's situation. This approach, a personalized medicine approach, directly challenges the notion of a one-size-fits-all mentality as it relates to treating medical problems. And to be sure, Dr. Bredesen is demonstrating incredible success not just in stabilizing Alzheimer's patients but actually in bringing about their improvement. This is revolutionary, and I urge you to pay close attention to his message today. ==== Dr. Bredesen received his undergraduate degree from Caltech and his medical degree from Duke. He served as Resident and Chief Resident in Neurology at UCSF, then was postdoctoral fellow in the laboratory of Nobel laureate Prof. Stanley Prusiner. He was a faculty member at UCLA from 1989-1994, then was recruited by the Burnham Institute to direct the Program on Aging. In 1998 he became the Founding President and CEO of the Buck Institute for Research on Aging, and Adjunct Professor at UCSF; then in 2013 he returned to UCLA as the Director of the Easton Center for Alzheimer’s Disease Research. The Bredesen Laboratory studies basic mechanisms underlying the neurodegenerative process, and the translation of this knowledge into effective therapeutics for Alzheimer’s disease and other neurodegenerative conditions, leading to the publication of over 220 research papers. He established the ADDN (Alzheimer’s Drug Development Network) with Dr. Varghese John in 2008, leading to the identification of new classes of therapeutics for Alzheimer’s disease. He and his group developed a new approach to the treatment of Alzheimer’s disease, and this approach led to the discovery of subtypes of Alzheimer’s disease, followed by the first description of reversal of symptoms in patients with MCI and Alzheimer’s disease, with the ReCODE (reversal of cognitive decline) protocol, published in 2014, 2016, and 2018. Dr. Bredesen is the author of the New York Times bestseller, The End of Alzheimer’s, and the newly released, The End of Alzheimer’s Program. His newest book, The First Survivors of Alzheimer’s, chronicles how this program has virtually rewritten the lives of so many, and reveals, from the patient’s perspective, what this has meant. Here’s a link to his latest research paper showing improvement in an astounding 80% of Alzheimer’s patients: https://www.drperlmutter.com/study/precision-medicine-approach-alzheimers-disease-successful-proof-concept-trial/ Twitter @DrDaleBredesen FB @drdalebredesen IG @drdalebredesen ___________________________ Instagram: https://www.instagram.com/davidperlmutter/ Website: https://www.drperlmutter.com/ Subscribe to our channel: https://www.youtube.com/channel/UCDRl_UAXxbHyOOjklnA0dxQ/?sub_confirmation=1

Compared with a usual diet supplemented with low-fat healthy-eating guidelines, patients on the ketogenic diet improved in daily function and quality of...

Drs. Ayesha and Dean Sherzai are the authors of The 30-Day Alzheimer’s Solution. It is most user-friendly book dedicated to brain health.

Drugs being used to treat Alzheimer’s disease are actually associated with a more aggressive decline in cognitive function.

Exercise, which has a positive impact on brain health, needs to be front and center in terms of our Alzheimer’s messaging and outreach.

A new study highlights the role lifestyle factors, like sleep, exercise, stress, and weight gain can have on your risk of developing Alzheimer's disease.

Do you ever worry about you or a loved one getting Alzheimer’s disease? It’s heartbreaking to watch someone you love not remember who you are or have difficulties with everyday tasks. The sacred plant is effective in preventing these symptoms of cognitive decline by reducing brain inflammation due to aging and by restoring a process called neurogenesis. Watch as Dr. Daniel Stein, a cannabis Neurologist, shares what he refers to as a “type 3” preventative protocol. *** This limited clip is a preview from our Healing Brain Masterclass. Get full access to our entire 3 masterclass library, complete season 1 docuseries, and over 37 bonuses on a portable 100+ GB flash drive... Go here for all the details 👉 http://bit.ly/2rl3F33

New research has found a way to partially restore brain cell communication around areas damaged by plaques associated with Alzheimer's disease.

Apolipoprotein E (apoE) is a lipid carrier in both the peripheral and the central nervous systems. Lipid-loaded apoE lipoprotein particles bind to several cell surface receptors to support membrane homeostasis and injury repair in the brain. Considering prevalence and relative risk magnitude, the ε4 …

The Alzheimer's brain can't handle glucose effectively, which is why this unique saturated fat may hold the key to improving and even reversing the condition in some patients

New research connects some very important dots and gives further substantiation to the idea that coffee is good for the brain.

Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder. As the aging population is increasing, AD is becoming one of the leading causes of disability and death among the elderly. However, currently there is no cure for this disease. Fucoidan is a complex sulfated polysaccharide ma

Europe PMC is an archive of life sciences journal literature.

This is a journal and virtual library useful to scientists, physicians and patients. The site contains medical and biology information as articles, databases, books, lectures and more. The site also contains the forms to search the most useful sites on the Web.

Alzheimer's disease is a neurodegenerative disorder involving extracellular plaques (amyloid-β) and intracellular tangles of tau protein. Recently, tangle formation has been identified as a major event involved in the neurodegenerative process, due to the conversion of either soluble peptides or oli …

Omega-3 fatty acids are known to be good for heart health, but did you know that in high doses they may also slow cognitive decline?

Muses Labs, partnering with leading Alzheimer's researchers, pioneered the MEND™ Protocol to treat underlying drivers of Alzheimer’s disease with big-data.

Dementia and Alzheimer's a big problem in industrialized countries. With the aging population at greater and greater risk for these conditions, it is imperative to understand that there are a variety of natural ways to stop dementia in its tracks. In this video, Dr. Osborne breaks down 6 natural ways you can overcome brain inflammation (brainflammation) including: 1. Avoid gluten 2. Eat lots of healthy fats 3. Avoid eating excessive carbohydrates 4. Take exercise more seriously 5. Maintain a healthy blood sugar 6. Do a medication review with your doctor. Remember, natural help is all about your diet and your lifestyle. There are no magic cures. You have to put in the work. To connect with Dr. Osborne visit: Facebook: https://www.facebook.com/DoctorPeterO... Pinterest: https://www.pinterest.com/docosborne/ Instagram: https://www.instagram.com/drosborne Twitter: https://twitter.com/glutenology *These statements have not been evaluated by the Food and Drug Administration. This video is not intended to diagnose, treat, cure or prevent any disease. It is strictly intended for educational purposes only. Additionally, this information is not intended to replace the advice of your physician. Dr. Osborne is not a medical doctor. He does not treat or diagnose disease. He offers nutritional support to people seeking an alternative from traditional medicine. Dr. Osborne is licensed with the Pastoral Medical Association.

A new study provides additional evidence that amyloid-beta protein -- which is deposited in the form of beta-amyloid plaques in the brains of patients with Alzheimer's disease -- is a normal part of the innate immune system, the body's first-line defense against infection.

In a new study, compared with the standard diet, patients on the ketogenic diet showed a small trend towards improved cognition.

Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier of people with early Alzheimer's disease, according to a new study. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.